Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 225,740 shares at $66.37 ($14.9M) on 2024-08-19, disclosed to the SEC on 2024-08-19.
Scheduled sale ($14.9M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.33 | 70,132 | $4.6M | 30.8% |
| 2 | $65.33 | 70,132 | $4.6M | 30.8% |
| 3 | $66.37 | 31,442 | $2.1M | 14.0% |
| 4 | $66.37 | 31,442 | $2.1M | 14.0% |
| 5 | $67.12 | 11,296 | $758K | 5.1% |
| 6 | $67.12 | 11,296 |
| $758K |
| 5.1% |
| Total | $65.80 avg | 225,740 | $14.9M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $2.7M | — | Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2025-01-06 | $15.8M | — | Filing → |